Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Drug development pharmacogenomics-based

The same pharmacogenomics-based subdivision of disease populations that stands to help Big Pharma narrow its focus will also lead to market segmentation that opens the door for smaller entities to move into the pharmaceutical business. Traditionally, the costs of research, development, clinical trials, and marketing for drugs have been so staggering and the risks of... [Pg.134]

See other pages where Drug development pharmacogenomics-based is mentioned: [Pg.317]    [Pg.330]    [Pg.12]    [Pg.37]    [Pg.110]    [Pg.516]    [Pg.519]    [Pg.54]    [Pg.128]    [Pg.132]    [Pg.135]    [Pg.228]    [Pg.229]    [Pg.230]    [Pg.231]    [Pg.231]    [Pg.232]    [Pg.242]    [Pg.244]    [Pg.246]    [Pg.276]    [Pg.290]    [Pg.317]    [Pg.220]    [Pg.329]    [Pg.367]    [Pg.84]    [Pg.543]    [Pg.31]    [Pg.39]    [Pg.640]    [Pg.642]    [Pg.281]    [Pg.31]    [Pg.326]    [Pg.646]    [Pg.155]    [Pg.65]    [Pg.203]    [Pg.214]    [Pg.221]    [Pg.262]    [Pg.52]    [Pg.437]    [Pg.406]    [Pg.174]    [Pg.174]    [Pg.477]    [Pg.154]   
See also in sourсe #XX -- [ Pg.229 ]



SEARCH



Drug development pharmacogenomics

Pharmacogenomic

Pharmacogenomics

Pharmacogenomics development

© 2024 chempedia.info